Baheal Pharma Group is a China-based health industry group for medical innovation incubation, manufacturing and commercialization.  Baheal Medical (Stock Code: 301015.SZ) serves as a medical commercialization platform with several brands with annual revenues exceeding 1 billion RMB each, its marketing network covers 14,000 hospitals and 400,000 pharmacies.

For technology innovation, Baheal cooperates with national research institutions to discover original innovations based on basic biological R&D and innovative achievements with First-in-Class potential. We are looking for global partners for the development and commercialization of innovate medicine outside China.